Join
Live feed
·
PRReleasevia Quantisnow
GSK plc logo

Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer

ByQuantisnow·Wall Street's wire, on your screen.
GSK· GSK plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GSK (GSK plc) and more on Quantisnow.